Arkolith/Insider Trading/ALGS/Form 4

Quan Lucinda Y.

See RemarksAligos Therapeutics, Inc. (ALGS) · full profile →Form 4 · filed Jul 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2022Grant(A)53K—$053K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-013869) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML